Literature DB >> 27259809

MicroRNA-505 suppresses proliferation and invasion in hepatoma cells by directly targeting high-mobility group box 1.

Lin Lu1, Chunyu Qiu2, Dongsheng Li3, Guang Bai1, Jian Liang4, Qing Yang5.   

Abstract

AIMS: MicroRNA-505 (miR-505) expressions have been reported to be altered in the serum of HCC patients. However, the effect and underlying mechanism of miR-505 in hepatoma cells remains poorly understood. The present study intended to investigate the expression levels and the probable role and molecular basis of miR-505 in hepatoma cells. MAIN
METHODS: Real-time PCR was used to determine the miR-505 expressions in hepatoma cell lines QGY-7703, SMMC-7721 and MHCC97. Furthermore, an up-or down-regulation of miR-505 was performed in MHCC97 by transfected with miR-505 mimics or anti-miR-505, respectively. Cell proliferation, cell invasion, and epithelial-mesenchymal transition were determined. Moreover, the target gene of miR-505 was also investigated. KEY
FINDINGS: The expressions of miR-505 were down-regulated in three hepatoma cell lines. MHCC97 possessed the lowest miR-505 levels among the three hepatoma cell lines. Furthermore, the up-regulation of miR-505 suppressed, whereas the down-regulation of miR-505 promoted proliferation, invasion and epithelial-mesenchymal transition in MHCC97. Moreover, miR-505 could directly bind to the 3'-untranslated region of High-Mobility Group Box 1. Notably, High-Mobility Group Box 1 knockdown apparently promoted cell proliferation and invasion in MHCC97. SIGNIFICANCE: We investigated that MiR-505 regulates proliferation and invasion in MHCC97 cells via targeting High-Mobility Group Box 1.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatoma cells; High-Mobility Group Box 1; Invasion; MicroRNA-505; Proliferation

Mesh:

Substances:

Year:  2016        PMID: 27259809     DOI: 10.1016/j.lfs.2016.05.039

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Differential microRNA expression in cultured palatal fibroblasts from infants with cleft palate and controls.

Authors:  Christian Schoen; Jeffrey C Glennon; Shaghayegh Abghari; Marjon Bloemen; Armaz Aschrafi; Carine E L Carels; Johannes W Von den Hoff
Journal:  Eur J Orthod       Date:  2018-01-23       Impact factor: 3.075

2.  Role of miR-653 and miR-29c in downregulation of CYP1A2 expression in hepatocellular carcinoma.

Authors:  Martin Krkoška; Jana Nekvindová; Kateřina Nevědělová; Veronika Zubáňová; Lenka Radová; Jan Vondráček; Jarmila Herůdková; Ondřej Slabý; Igor Kiss; Lucia Bohovicová; Pavel Fabian; Zuzana Tylichová; Zdeněk Kala; Petr Kysela; Lenka Ostřížková; Vladimír Palička; Alena Hyršlová Vaculová
Journal:  Pharmacol Rep       Date:  2021-11-15       Impact factor: 3.024

3.  MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion.

Authors:  Yu-Jiang Liu; Wei Li; Feng Chang; Jian-Na Liu; Jun-Xin Lin; De-Xi Chen
Journal:  Oncol Rep       Date:  2017-12-11       Impact factor: 3.906

Review 4.  MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.

Authors:  Jianing Yan; Shibo Ying; Xiujun Cai
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

5.  Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression.

Authors:  Giridhar Mudduluru; Katharina Ilm; Steffen Fuchs; Ulrike Stein
Journal:  Oncotarget       Date:  2017-03-28

6.  A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma.

Authors:  Chiao-Wen Lin; Ying-Erh Chou; Chia-Ming Yeh; Shun-Fa Yang; Chun-Yi Chuang; Yu-Fan Liu
Journal:  Oncotarget       Date:  2017-05-23

7.  A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis.

Authors:  Jie Liu; Yue Xiao; Xikun Wu; Lichun Jiang; Shurong Yang; Zhiming Ding; Zhuo Fang; Haiqing Hua; Mark Stephen Kirby; Jianyong Shou
Journal:  BMC Genomics       Date:  2018-03-09       Impact factor: 3.969

8.  MicroRNA-505-3p inhibits development of glioma by targeting HMGB1 and regulating AKT expression.

Authors:  Zhenlin Cheng; Bin Wang; Cheng Zhang
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

9.  Elevated Expression of PDZD11 Is Associated With Poor Prognosis and Immune Infiltrates in Hepatocellular Carcinoma.

Authors:  Yao Chen; Haifeng Xie; Ting Xie; Xunjun Yang; Yilin Pang; SongDao Ye
Journal:  Front Genet       Date:  2021-05-21       Impact factor: 4.599

10.  Abnormal expression of HMGB-3 is significantly associated with malignant transformation of hepatocytes.

Authors:  Wen-Jie Zheng; Min Yao; Miao Fang; Li Wang; Zhi-Zhen Dong; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2018-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.